News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
The COVID Working Group chaired by Dr N K Arora had recommended extension of the gap between the first and second doses of COVISHIELD vaccine to 12-16 weeks. This has been accepted by Government of India on 13th May 2021.
Regardless where you live in the world there is no hiding from the fact that many people’s lives are undergoing a great deal of change and stress. Lack of sleep, poor nutrition and life stress everything leads to a weakened immune system and vulnerability to sickness and stress more than anything. It completely leads to a breakdown in the body’s ability to defend itself against any bacteria or viruses and that’s what Covid is thriving on, a weakened immune system.
India is helping state run firms—Haffkine Biopharmaceutical Corporation Ltd, Indian Immunologicals Ltd (IIL) and Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL)— to gear up for manufacturing Covaxin to help meet the vaccine shortage in the country.
India will have enough doses to inoculate all citizens by December, the head of the national task force on Covid-19 vaccines said on Thursday, dangling the prospect of a final victory against a virus that is now devastating homes and families across the country.
A sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to patients suffering from Mucormycosis, a post COVID-19 complication. The Government of India is therefore engaging with the manufacturers to ramp up production of the drug. The supply position is expected to improve with extra imports of this drug and increase in its production domestically.
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (“Lilly”) for expanding access to Lilly’s drug, baricitinib in India. Sun Pharma will manufacture and distribute the drug in India.
To help suspicious patients diagnose Covid-19 faster, the Defense Research and Development Organization (DRDO) and the Center for Artificial Intelligence and Robotics (CAIR) have launched an artificial intelligence (AI) algorithm designed to help detect Covid-19 using the chest X-ray According to its developers, a tool called Atman AI used to detect chest X-rays shows an accuracy of 96.73%.
Amid the COVID-19 vaccine shortage and criticism aimed at Modi government, Macron asserted that India does not need to be ‘lectured from anyone’
An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from COVID-19.
Ex-Defence doctors will now provide online consultation on e-Sanjeevani OPD to all citizens of the country. Veterans have come forward to answer the call of the nation and offered their services to help the people needing medical care. Defence Secretary Dr Ajay Kumar and Director General of Armed Forces Medical Services (AFMS) Surgeon Vice Admiral Rajat Datta addressed the veterans who have come forward to offer their services, through video conferencing on May 07, 2021. This service can be availed by any civilian on the website https://esanjeevaniopd.in/.
